Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.

We investigated the mechanism of action of the ACE inhibitor-induced increase in cardiac capillary length density. Stroke-prone spontaneously hypertensive rats were treated prenatally and up to the age of 20 weeks with the ACE inhibitor ramipril (0.01 and 1 mg/kg per day PO) and the AT1 receptor antagonist losartan (30 mg/kg per day PO). The contribution of endogenous bradykinin potentiation to the ACE inhibitor actions was assessed by cotreatment with the bradykinin B2-receptor antagonist Icatibant (0.5 mg/kg per day, SC via osmotic minipumps) from 6 to 20 weeks of age. At the end of the treatment period, cardiac capillary length density was measured stereologically using the orientator method. The development of hypertension and left ventricular hypertrophy was prevented by high- but not low-dose ramipril and was not affected by chronic bradykinin B2-receptor blockade. Low- and high-dose ramipril significantly increased cardiac capillary length density (3577 +/- 279, n = 11 and 3988 +/- 300 mm/mm3; n = 10; P < .05) compared with vehicle-treated animals (2935 +/- 137 mm/mm3; n = 13). These effects were abolished by chronic bradykinin B2-receptor blockade. The bradykinin antagonist alone was without effect on cardiac capillary length density. Losartan prevented hypertension and left ventricular hypertrophy but did not significantly alter cardiac capillary length density (3429 +/- 309 mm/mm3; n = 7). Our results demonstrate that chronic ACE inhibitor treatment can increase cardiac capillary length density in stroke-prone spontaneously hypertensive rats independently of a reduction in blood pressure or left ventricular hypertrophy. This effect is related to the ACE inhibitor-induced potentiation of endogenous bradykinin since it was prevented by chronic bradykinin B2-receptor blockade and was not observed following antihypertensive treatment with the AT1-receptor antagonist losartan.

[1]  P. Okin,et al.  Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[2]  T. Unger,et al.  Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. , 1996, Hypertension.

[3]  A. Greene,et al.  Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. , 1996, Hypertension.

[4]  R. Morishita,et al.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Campbell,et al.  Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin‐Converting Enzyme , 1995, Journal of cardiovascular pharmacology.

[6]  X. Xu,et al.  Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. , 1995, Hypertension.

[7]  T. Unger,et al.  Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. , 1995, Pharmacological reviews.

[8]  M. Paul,et al.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. , 1995, The Journal of clinical investigation.

[9]  C. Tschöpe,et al.  Potential effects of bradykinin on myocardial capillary growth after angiotensin converting enzyme inhibition , 1994 .

[10]  T. Unger,et al.  Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. , 1994, Hypertension.

[11]  T. Unger,et al.  Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate. , 1993, Hypertension.

[12]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[13]  P. Timmermans,et al.  Angiotensin II receptors and angiotensin II receptor antagonists. , 1993, Pharmacological reviews.

[14]  T. TorresAlvarez.  Factors related to satisfaction with life in retired factory workers of rural origen , 1993 .

[15]  E. Ongini,et al.  Spirapril Prevents Left Ventricular Hypertrophy, Decreases Myocardial Damage and Promotes Angiogenesis in Spontaneously Hypertensive Rats , 1993, Journal of cardiovascular pharmacology.

[16]  T. Mattfeldt,et al.  Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. , 1992, Hypertension.

[17]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[18]  T. Unger,et al.  Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. , 1992, Hypertension.

[19]  H. Granger,et al.  Activation of DNA synthesis and inositol-phosphate turnover in coronary venular endothelial cells exposed to bradykinin☆ , 1992 .

[20]  S. Egginton,et al.  Angiogenesis in skeletal and cardiac muscle. , 1992, Physiological reviews.

[21]  T. Mattfeldt,et al.  Estimation of surface area and length with the orientator , 1990, Journal of microscopy.

[22]  J. Montani,et al.  Growth regulation of the vascular system: evidence for a metabolic hypothesis. , 1990, The American journal of physiology.

[23]  J. Clozel,et al.  Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. , 1989, Journal of hypertension.

[24]  T. Mattfeldt,et al.  Growth of capillaries and myocardial cells in the normal rat heart. , 1987, Journal of molecular and cellular cardiology.

[25]  Skidgel Ra,et al.  The angiotensin I-converting enzyme. , 1977 .